Quick Takeaways
- EcoR1 Capital, LLC filed SCHEDULE 13G for ORIC Pharmaceuticals, Inc. Common Stock (ORIC).
- Disclosed ownership: 6.9%.
- Date of event: 29 Jul 2025.
EcoR1 Capital, LLC - 29 Jul 2025 SCHEDULE 13G Report for ORIC Pharmaceuticals, Inc. Common Stock (ORIC)
- Filing Manager
- EcoR1 Capital, LLC
- Reporting Manager
- EcoR1 Capital, LLC
- Symbol
- ORIC
- Shares outstanding
- 97,508,928 shares
- Disclosed Ownership
- 6,728,116 shares
- Ownership
- 6.9%
- Form type
- SCHEDULE 13G
- Filing time
- 05 Aug 2025, 18:36:54 UTC
- Date of event
- 29 Jul 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"EcoR1 Capital, LLC disclosed 6.9% ownership in ORIC Pharmaceuticals, Inc. Common Stock (ORIC) on 29 Jul 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 05 Aug 2025, 18:36.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| EcoR1 Capital, LLC | 6.9% | 6,728,116 | 0 | 6,728,116 | /s/ Oleg Nodelman | Manager | |
| Oleg Nodelman | 6.9% | 6,728,116 | 0 | 6,728,116 | /s/ Oleg Nodelman | Reporting person | |
| EcoR1 Capital Fund Qualified, L.P. | 6.5% | 6,283,426 | 0 | 6,283,426 | /s/ Oleg Nodelman | Manager of the General Partner, EcoR1 Capital, LLC |